Jane E Staunton

Title: Jane E Staunton: Innovator in Chemosensitivity Prediction

Introduction

Jane E Staunton is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of biomedical research, particularly in the area of predicting chemosensitivity and chemoresistance. Her work has the potential to impact cancer treatment and patient outcomes significantly.

Latest Patents

Jane E Staunton holds 1 patent for her innovative methods and apparatus for classifying or predicting the classes for samples based on gene expression. Her patent describes methods for ascertaining or discovering new, previously unknown classes based on gene expression. Additionally, it provides methods and computer systems for predicting whether a sample is treatment sensitive or resistant, based on the analysis of gene expression data from samples subjected to various compounds.

Career Highlights

Throughout her career, Jane has worked with esteemed institutions such as the Whitehead Institute for Biomedical Research and Dana-Farber Cancer Institute Inc. Her research has focused on enhancing the understanding of how gene expression can inform treatment strategies for cancer patients.

Collaborations

Jane has collaborated with notable colleagues, including Pablo Tamayo and Donna K Slonim. Their combined expertise has contributed to advancing research in the field of cancer treatment.

Conclusion

Jane E Staunton's innovative work in predicting chemosensitivity and chemoresistance showcases her dedication to improving cancer treatment methodologies. Her contributions to biomedical research continue to pave the way for advancements in personalized medicine.